API 0.74% $1.35 australian pharmaceutical industries limited

announcement stock adjustment, page-4

  1. 4,770 Posts.
    re: a value buy. Well I've bought a lot of stock and have a significant holding and have made it clear publicly that Sigma tried to get it cheap- go figure.

    This stock was a $3/2.70 share but for this one off stuff. I think the company is capable of outperforming Sigma which has in recent times dictated the share price.

    Rest assured that I am in profit. I am a buyer. I would love to buy it at the brokers prices under $2 but alas that will not happen.

    This is an ideal LBO if it ever dipped. The stock is held almost 50% by the top 5 holders. The rest of the stock is largely held by entrenched pharmacists who like the company and think well of it but who in the main disliked the now dumped management.

    Note the stock actually rose and closed higher after initially plunging on Friday when SIP made its asx release. I was waiting and topped up.

    What do you think Raboshan?
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.